482 related articles for article (PubMed ID: 24861558)
1. Flexible and extended dosing of nicotine replacement therapy or varenicline in comparison to fixed dose nicotine replacement therapy for smoking cessation: rationale, methods and participant characteristics of the FLEX trial.
Tulloch H; Pipe A; Els C; Aitken D; Clyde M; Corran B; Reid RD
Contemp Clin Trials; 2014 Jul; 38(2):304-13. PubMed ID: 24861558
[TBL] [Abstract][Full Text] [Related]
2. Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial.
Tulloch HE; Pipe AL; Els C; Clyde MJ; Reid RD
BMC Med; 2016 Jun; 14():80. PubMed ID: 27233840
[TBL] [Abstract][Full Text] [Related]
3. Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness.
Stapleton JA; Watson L; Spirling LI; Smith R; Milbrandt A; Ratcliffe M; Sutherland G
Addiction; 2008 Jan; 103(1):146-54. PubMed ID: 18028247
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial.
Koegelenberg CF; Noor F; Bateman ED; van Zyl-Smit RN; Bruning A; O'Brien JA; Smith C; Abdool-Gaffar MS; Emanuel S; Esterhuizen TM; Irusen EM
JAMA; 2014 Jul; 312(2):155-61. PubMed ID: 25005652
[TBL] [Abstract][Full Text] [Related]
5. Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial.
Baker TB; Piper ME; Stein JH; Smith SS; Bolt DM; Fraser DL; Fiore MC
JAMA; 2016 Jan; 315(4):371-9. PubMed ID: 26813210
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents.
Bailey SR; Crew EE; Riske EC; Ammerman S; Robinson TN; Killen JD
Paediatr Drugs; 2012 Apr; 14(2):91-108. PubMed ID: 22248234
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and abstinence outcomes among tobacco quitline enrollees using varenicline or nicotine replacement therapy.
Biazzo LL; Froshaug DB; Harwell TS; Beck HN; Haugland C; Campbell SL; Helgerson SD
Nicotine Tob Res; 2010 Jun; 12(6):567-73. PubMed ID: 20378640
[TBL] [Abstract][Full Text] [Related]
8. Combination treatment with varenicline and nicotine replacement therapy.
Ebbert JO; Burke MV; Hays JT; Hurt RD
Nicotine Tob Res; 2009 May; 11(5):572-6. PubMed ID: 19351781
[TBL] [Abstract][Full Text] [Related]
9. Use of varenicline for 4 weeks before quitting smoking: decrease in ad lib smoking and increase in smoking cessation rates.
Hajek P; McRobbie HJ; Myers KE; Stapleton J; Dhanji AR
Arch Intern Med; 2011 Apr; 171(8):770-7. PubMed ID: 21518946
[TBL] [Abstract][Full Text] [Related]
10. Varenicline in the management of smoking cessation: a single technology appraisal.
Hind D; Tappenden P; Peters J; Kenjegalieva K
Health Technol Assess; 2009 Sep; 13 Suppl 2():9-13. PubMed ID: 19804684
[TBL] [Abstract][Full Text] [Related]
11. Is a combination of varenicline and nicotine patch more effective in helping smokers quit than varenicline alone? A randomised controlled trial.
Hajek P; Smith KM; Dhanji AR; McRobbie H
BMC Med; 2013 May; 11():140. PubMed ID: 23718718
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of COPD smokers and effectiveness and safety of smoking cessation medications.
Jiménez Ruiz CA; Ramos Pinedo A; Cicero Guerrero A; Mayayo Ulibarri M; Cristobal Fernández M; Lopez Gonzalez G
Nicotine Tob Res; 2012 Sep; 14(9):1035-9. PubMed ID: 22345320
[TBL] [Abstract][Full Text] [Related]
13. Varenicline versus transdermal nicotine patch: a 3-year follow-up in a smoking cessation clinic in Taiwan.
Hsueh KC; Hsueh SC; Chou MY; Pan LF; Tu MS; McEwen A; West R
Psychopharmacology (Berl); 2014 Jul; 231(14):2819-23. PubMed ID: 24522334
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation.
Oncken C; Gonzales D; Nides M; Rennard S; Watsky E; Billing CB; Anziano R; Reeves K
Arch Intern Med; 2006 Aug 14-28; 166(15):1571-7. PubMed ID: 16908789
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled open comparative trial of varenicline vs nicotine patch in adult smokers: efficacy, safety and withdrawal symptoms (the VN-SEESAW study).
Tsukahara H; Noda K; Saku K
Circ J; 2010 Apr; 74(4):771-8. PubMed ID: 20154405
[TBL] [Abstract][Full Text] [Related]
16. Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial.
Aubin HJ; Bobak A; Britton JR; Oncken C; Billing CB; Gong J; Williams KE; Reeves KR
Thorax; 2008 Aug; 63(8):717-24. PubMed ID: 18263663
[TBL] [Abstract][Full Text] [Related]
17. Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal.
Cinciripini PM; Robinson JD; Karam-Hage M; Minnix JA; Lam C; Versace F; Brown VL; Engelmann JM; Wetter DW
JAMA Psychiatry; 2013 May; 70(5):522-33. PubMed ID: 23536105
[TBL] [Abstract][Full Text] [Related]
18. Varenicline to stop long-term nicotine replacement use: a double-blind, randomized, placebo-controlled trial.
Tønnesen P; Mikkelsen K
Nicotine Tob Res; 2013 Feb; 15(2):419-27. PubMed ID: 23024246
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of varenicline for smoking cessation at 2 urban academic health centers.
Dhelaria RK; Friderici J; Wu K; Gupta E; Khan C; Rothberg MB
Eur J Intern Med; 2012 Jul; 23(5):461-4. PubMed ID: 22726377
[TBL] [Abstract][Full Text] [Related]
20. Fifty-two-week continuous abstinence rates of smokers being treated with varenicline versus nicotine replacement therapy.
Kralikova E; Kmetova A; Stepankova L; Zvolska K; Davis R; West R
Addiction; 2013 Aug; 108(8):1497-502. PubMed ID: 23668486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
